We’re getting ready for the 2012 Gastrointestinal Cancers Symposium next week at the Moscone Center in San Francisco.
Kim Ryan, Nancy Roach, and I will be there checking out the latest colon and rectal cancer prevention and treatment research and talking with leaders in the colorectal cancer field.
Colon and rectal cancer is featured on Saturday, January 21, but we’ll also be looking at research results for cancers in the upper digestive tract, liver, and pancreas on Thursday and Friday, visiting exhibits, and meeting with members of the Fight Colorectal Cancer Medical Advisory Board.
- Watch for our reports from the Symposium on the Fight Colorectal Cancer Research and Treatment News.
- Follow our tweets on Twitter @FightCRC.
- In February, join us and Dr. Dan Sargent from the Mayo Clinic for a Report from the 2012 GI Cancers Symposium webinar.
Each year, ASCO gives a few posters special mention as Merit Awards. We’ll be stopping by to see those related to colorectal cancer.
- Association of NCCN guideline adherence with improved survival in high-risk stage II and stage III colon cancer. Genevieve Boland, MD, PhD, University of Texas M. D. Anderson Cancer Center.
- A 21-year analysis of lymph node trends in colon cancer: Do quality measures really matter? Danielle Hari, MD, John Wayne Cancer Institute at St. Johns Health Center.
- Association between delays in adjuvant chemotherapy for stage III colon cancer and increased mortality. Alex Haynes, MD, MPH, University of Texas M. D. Anderson Cancer Center.
- Lymph node metastasis in patients with early pathologic T-stage rectal cancers: What does local excision leave behind? Maria Russell, MD, University of Texas M. D. Anderson Cancer Center.
Stay tuned for more breaking research information as we bring it to you.